Pablo J Cagnoni's Net Worth

$17.2 Million

Estimate Recalculated Nov 11, 2024 02:43AM EST

Who is Pablo J Cagnoni?

Pablo J Cagnoni has an estimated net worth of $17.2 Million. This is based on reported shares across multiple companies, which include Fusion Pharmaceuticals Inc., CRISPR Therapeutics AG, Rubius Therapeutics, Inc., TURMERIC ACQUISITION CORP., INCYTE CORP, ALLOS THERAPEUTICS INC, ONYX PHARMACEUTICALS INC, and OSI PHARMACEUTICALS INC.

SEC CIK

Pablo J Cagnoni's CIK is 0001205703

Past Insider Trading and Trends

2018 was Pablo J Cagnoni's most active year for acquiring shares with 7 total transactions. Pablo J Cagnoni's most active month to acquire stocks was the month of May. 2004 was Pablo J Cagnoni's most active year for disposing of shares, totalling 13 transactions. Pablo J Cagnoni's most active month to dispose stocks was the month of July. 2007 saw Pablo J Cagnoni paying a total of $1,851,000.00 for 375,000 shares, this is the most they've acquired in one year. In 2013 Pablo J Cagnoni cashed out on 50,287 shares for a total of $2,032,125.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Fusion Pharmaceuticals Inc. (FUSN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$33.80
-$423,075.00
0
Scheduled
Nov 19
Form 4
—
0
$30.30
-$370,575.00
0
Scheduled
Nov 12
Form 4
—
0
$28.80
-$348,075.00
0
Scheduled
Oct 30
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
$33.80
-$423,075.00
0
Scheduled
Jul 3 - Jul 5
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Oct 18
Form 3
—
0
—
—
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057

CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.34%
-8.45K
$0.25
-$2,112.00
66.08K
Feb 1
Form 4
+109.83%
39.01K
$0.24
-$1,744.84
74.53K
Jan 29 - Jan 31
Form 4
+69.14%
14.52K
$6.57
-$44,236.29
35.52K
Jan 29 - Feb 1
Form 4
—
0
—
—
0
Jan 29
Form 4
∞
21K
$4.70
$98,693.70
21K
Apr 14
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Oct 31
Form 3
—
0
—
—
0
No matching records found

TURMERIC ACQUISITION CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

INCYTE CORP (INCY) Snapshot price: $60.96

President, R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.45%
19.1K
$64.25
-$48,123.25
221.17K
Jul 15
Form 4
—
0
—
—
0
Jan 18
Form 4
+5.02%
9.67K
—
—
202.07K
Jul 14
Form 4/A
∞
192.4K
—
—
192.4K
Jun 5
Form 4
∞
179.61K
—
—
179.61K
Jun 5
Form 3
—
0
—
—
0
No matching records found